BTBD9 and neoplasm: Finally, cluster 4 is distinguished by a low point mutation burden (~80 coding mutations per tumor) (Fig. 5j), as well as high expression of three genes (BTBD9, CDYL, TFAP2A) and high methylation at 100 promoters.